BioSpace News Archive

Forte Biosciences, Inc., a clinical-stage biopharmaceutical company, announced the issuance of an equity inducement award as required by the Nasdaq Stock Market Rules.

Geistlich Derma-Gide ® Added to the General Services Administration’s Federal Supply Schedule

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the appointment of George Llado, Senior Vice President and Chief Information Officer of Alexion Pharmaceuticals, Inc., to its Board of Directors. Mr. Llado’s extensive experience leading information technology (IT) organizations in the biopharmaceutical industry will enhance the technological expertise of Charles River’s Board of Directors. As a

Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today reported financial results for the fiscal quarter ended August 31, 2020. Net sales for the three months ended August 31, 2020 were $1.14 million compared to net sales of $1.19 million for the same period of 2019. Net loss was $1.6 million for the three months ended August 31, 2020 compared to a net loss of $0.5 million for the same period in the previous yea

- OMID Holdings, Inc. (OTC Pink: OMID), a publicly-traded health and wellness company, today provides Unaudited Key Financial Highlights for the third quarter. Operating Results for the Three Months Ended September 30, 2020 Revenue was $356,444 , compared to $178,435 for the same period last year, a 99.8% improvement. Gros

Opthea Limited (ASX:OPT, Nasdaq: OPT), a clinical stage biopharmaceutical company developing a novel therapy to treat highly prevalent and progressive retinal diseases, today announces the pricing of its initial public offering in the United States (the “Offering”) of 8,563,300 American Depositary Shares (“ADS”), representing 68,506,400 ordinary shares, at an initial public offering price of US$13.50 per ADS, before underwriting discounts

The $50 million Innovation and Research Park on the campus of Rosalind Franklin University of Medicine and Science secured its first occupant this month when Inspirotec, Inc. executed a five-year license agreement.

New scientific review article finds promising results when comparing fall rates in patients with and without surgery

Since the beginning of this unprecedented-worldwide-health-crisis, Carenity, a digital health start-up specialized in medical studies whose platform brings together nearly 400,000 patients worldwide, has decided to give a voice to its chronic patients’ communities, a population that is particularly vulnerable in this context.

Ortho Clinical Diagnostics (“Ortho”), today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to its proposed initial public offering. The number of shares to be offered and the price range for the proposed offering have not yet